CD56 Is an Unfavorable Prognostic Factor for Acute Promyelocytic Leukemia: Results By Multivariate Analyses in the JALSG-APL204 Study

被引：0

作者：

Takeshita, Akihiro ^{[1
]}

Asou, Norio ^{[2
]}

Atsuta, Yoshiko ^{[3
]}

Furumaki, Hiroaki ^{[1
]}

Sakura, Toru ^{[4
]}

Ueda, Yasunori ^{[5
]}

Sawa, Masashi ^{[6
]}

Dobashi, Nobuaki ^{[7
]}

Suzuki, Rikio ^{[8
]}

Taniguchi, Yasuhiro ^{[9
]}

Nakagawa, Masaru ^{[10
]}

Tamaki, Shigehisa ^{[11
]}

Hagihara, Maki ^{[12
]}

Fujimaki, Katsumichi ^{[13
]}

Yokoyama, Yasuhisa ^{[14
]}

Fujita, Hiroyuki ^{[15
]}

Yanada, Masamitsu ^{[16
]}

Maeda, Yoshinobu ^{[17
]}

Usui, Noriko ^{[18
]}

Kobayashi, Yukio ^{[19
]}

Kiyoi, Hitoshi ^{[20
]}

Ohtake, Shigeki ^{[21
]}

Matsumura, Itaru ^{[9
]}

Naoe, Tomoki ^{[22
]}

Miyazaki, Yasushi ^{[23
]}

机构：

[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan

[2] Saitama Med Univ, Int Med Ctr, Hidaka, Saitama, Japan

[3] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan

[4] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Maebashi, Gunma, Japan

[5] Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan

[6] Anjo Kosei Hosp, Anjo, Japan

[7] Jikei Univ, Dept Clin Oncol & Hematol, Daisan Hosp, Tokyo, Japan

[8] Tokai Univ, Sch Med, Isahara, Japan

[9] Kindai Univ, Fac Med, Osaka, Japan

[10] Nihon Univ, Sch Med, Tokyo, Japan

[11] Ise Red Cross Hosp, Ise, Japan

[12] Yokohama City Univ, Dept Hematol, Med Ctr, Yokohama, Kanagawa, Japan

[13] Fujisawa City Hosp, Fujisawa, Kanagawa, Japan

[14] Univ Tsukuba, Dept Hematol, Fac Med, Tsukuba, Ibaraki, Japan

[15] Yokohama City Univ, Dept Hematol & Clin Immunol, Grad Sch Med, Yokohama, Kanagawa, Japan

[16] Fujita Hlth Univ, Sch Med, Toyoake, Aichi, Japan

[17] Okayama Univ, Dept Hematol & Oncol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan

[18] Jikei Univ, Dept Internal Med, Div Clin Oncol & Hematol, Sch Med, Tokyo, Japan

[19] IUHW Mita Hosp, Div Hematol, Tokyo, Japan

[20] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan

[21] Kanazawa Univ, Kanazawa, Ishikawa, Japan

[22] Nagoya Med Ctr, Natl Hosp Org, Nagoya, Aichi, Japan

[23] Nagasaki Univ, Atom Bomb Dis Inst, Nagasaki, Japan

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-111638

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2798

引用

页数：3

共 50 条

[1] Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature
Takeshita, Akihiro
Asou, Norio
Atsuta, Yoshiko
Furumaki, Hiroaki
Sakura, Toru
Ueda, Yasunori
Sawa, Masashi
Dobashi, Nobuaki
Taniguchi, Yasuhiro
Suzuki, Rikio
Nakagawa, Masaru
Tamaki, Shigehisa
Hagihara, Maki
Fujimaki, Katsumichi
Minamiguchi, Hitoshi
Fujita, Hiroyuki
Yanada, Masamitsu
Maeda, Yoshinobu
Usui, Noriko
Kobayashi, Yukio
Kiyoi, Hitoshi
Ohtake, Shigeki
Matsumura, Itaru
Naoe, Tomoki
Miyazaki, Yasushi
CANCERS, 2020, 12 (06)
[2] Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts
Ono, Takaaki
Takeshita, Akihiro
Kishimoto, Yuji
Kiyoi, Hitoshi
Okada, Masaya
Yamauchi, Takahiro
Emi, Nobuhiko
Horikawa, Kentaro
Matsuda, Mitsuhiro
Shinagawa, Katsuji
Monma, Fumihiko
Ohtake, Shigeki
Nakaseko, Chiaki
Takahashi, Masatomo
Kimura, Yukihiko
Iwanaga, Masako
Asou, Norio
Naoe, Tomoki
CANCER SCIENCE, 2014, 105 (01) : 97 - 104
[3] Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study
Takeshita, Akihiro
Asou, Norio
Atsuta, Yoshiko
Sakura, Toru
Ueda, Yasunori
Sawa, Masashi
Dobashi, Nobuaki
Taniguchi, Yasuhiro
Suzuki, Rikio
Nakagawa, Masaru
Tamaki, Shigehisa
Hagihara, Maki
Fujimaki, Katsumichi
Furumaki, Hiroaki
Obata, Yukako
Fujita, Hiroyuki
Yanada, Masamitsu
Maeda, Yoshinobu
Usui, Noriko
Kobayashi, Yukio
Kiyoi, Hitoshi
Ohtake, Shigeki
Matsumura, Itaru
Naoe, Tomoki
Miyazaki, Yasushi
LEUKEMIA, 2019, 33 (02) : 358 - 370
[4] Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study
Akihiro Takeshita
Norio Asou
Yoshiko Atsuta
Toru Sakura
Yasunori Ueda
Masashi Sawa
Nobuaki Dobashi
Yasuhiro Taniguchi
Rikio Suzuki
Masaru Nakagawa
Shigehisa Tamaki
Maki Hagihara
Katsumichi Fujimaki
Hiroaki Furumaki
Yukako Obata
Hiroyuki Fujita
Masamitsu Yanada
Yoshinobu Maeda
Noriko Usui
Yukio Kobayashi
Hitoshi Kiyoi
Shigeki Ohtake
Itaru Matsumura
Tomoki Naoe
Yasushi Miyazaki
Leukemia, 2019, 33 : 358 - 370
[5] Clinical Features and Prognostic Impact of CD56 Expression in Acute Promyelocytic Leukemia: Long Term Follow up Data From the Japan Adult Leukemia Study Group(JALSG) APL97
Ono, Takaaki
Takeshita, Akihiro
Kishimoto, Yuji
Kiyoi, Hitoshi
Okada, Masaya
Yamauchi, Takahiro
Tsuzuki, Motohiro
Horikawa, Kentaro
Matsuda, Mitsuhiro
Shinagawa, Katsuji
Monma, Fumihiko
Ohtake, Shigeki
Nakaseko, Chiaki
Takahashi, Masatomo
Yagasaki, Fumiharu
Kimura, Yukihiko
Fujita, Hiroyuki
Iwanaga, Masako
Asou, Norio
Ohnishi, Kazunori
Naoe, Tomoki
BLOOD, 2011, 118 (21) : 1540 - 1541
[6] Tamibarotene As Maintenance Therapy for Acute Promyelocytic Leukemia Improved Long Term Relapse-Free Survival: 7-Year Results from a Randomized Controlled Trial, JALSG-APL204
Takeshita, Akihiro
Asou, Norio
Yanada, Masamitsu
Sakura, Toru
Ueda, Yasunori
Sawa, Masashi
Dobashi, Nobuaki
Onizuka, Makoto
Taniguchi, Yasuhiro
Nakagawa, Masaru
Tamaki, Shigehisa
Hagihara, Maki
Fujimaki, Katsumichi
Furumaki, Hiroaki
Fujita, Hiroyuki
Usui, Noriko
Kobayashi, Yukio
Kiyoi, Hitoshi
Ohtake, Shigeki
Atsuta, Yoshiko
Matsumura, Itaru
Naoe, Tomoki
Miyazaki, Yasushi
BLOOD, 2017, 130
[7] Obesity Is a Poor Prognostic Factor In Acute Promyelocytic Leukemia (APL)
Hatta, Yoshihiro
Horikoshi, Akira
Kurita, Daisuke
Kobayashi, Sumiko
Kobayashi, Yujin
Kura, Yoshimasa
Kodaira, Hitomi
Inoue, Yasuyuki
Miura, Katsuhiro
Kiso, Satomi
Takahashi, Hiromichi
Ishizuka, Hikari
Tanaka, Toshitake
Yagi, Mai
Hojo, Atsuko
Hirabayashi, Yukio
Uchino, Yoshihito
Iriyama, Noriyoshi
Sawada, Umihiko
Takeuchi, Jin
BLOOD, 2010, 116 (21) : 457 - 457
[8] CD56 EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA - A PREDICTIVE INDICATOR OF RELAPSE?
Ramalheira, S.
Moreira, C.
Ferreira, C.
Leite, L.
Pereira, D.
Nunes, M.
Brito, M.
Silva, P.
Silva, R.
Martins, A.
Moreira, I.
Oliveira, I.
Viterbo, L.
Domingues, N.
Chacim, S.
Sousa, E.
Godinho, I.
Martins, G.
Mendes, C.
Santo, A.
Mariz, J.
HAEMATOLOGICA, 2013, 98 : 519 - 519
[9] Expression of CD56 Is an Independent Prognostic Factor to Predict Relapse in Acute Myeloid Leukemia with t(8;21): Results of Japan Adult Leukemia Study Group (JALSG) AML97 Protocol
Iriyama, Noriyoshi
Hatta, Yoshihiro
Takeuchi, Jin
Ogawa, Yoshiaki
Ohtake, Shigeki
Sakura, Toru
Mitani, Kinuko
Ishida, Fumihiro
Takahashi, Masatomo
Maeda, Tomoya
Izumi, Tohru
Sakamaki, Hisashi
Miyawaki, Shuichi
Honda, Sumihisa
Miyazaki, Yasushi
Taki, Tomohiko
Taniwaki, Masafumi
Naoe, Tomoki
BLOOD, 2012, 120 (21)
[10] Aberrant phenotypic expression of CD15 and CD56 identifies poor prognostic acute promyelocytic leukemia patients
Breccia, Massimo
De Propris, Maria Stefania
Minotti, Clara
Stefanizzi, Caterina
Raponi, Sara
Colafigli, Gioia
Latagliata, Roberto
Guarini, Anna
Foa, Robin
LEUKEMIA RESEARCH, 2014, 38 (02) : 194 - 197

← 1 2 3 4 5 →